
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-05-21 10:10:22Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Krebs Biochemicals & Industries Ltd Locks at Lower Circuit With 4.02% Loss — Sellers Queue, No Buyers in Sight
2026-05-20 12:00:07At Rs 55.58, Krebs Biochemicals & Industries Ltd locked at its lower circuit of 4.02% on 20 May 2026, with sellers lined up but no buyers willing to absorb the supply. The 5% price band limited the daily loss, yet the unfilled sell orders highlight persistent selling pressure and a frozen price.
Read More
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-05-10 10:10:15Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 10 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook.
Read MoreWhen is the next results date for Krebs Biochemicals & Industries Ltd?
2026-05-08 23:16:50The next results date for Krebs Biochemicals & Industries Ltd is scheduled for 21 May 2026....
Read More
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-04-29 10:10:20Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read More
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 4.98% Gain — Buyers Queue, Sellers Absent
2026-04-21 11:00:05At Rs 62.34, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Krebs Biochemicals & Industries Ltd locked at its upper circuit of 4.98% on 21 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-04-18 10:10:14Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent
2026-04-06 11:00:05At Rs 57.15, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Krebs Biochemicals & Industries Ltd locked at its upper circuit of 20% on 6 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-03-27 10:10:15Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreCompliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSEThe Company has enclosed herewith Annual Secretarial Complince Report for the yaer ended 31.03.2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
22-May-2026 | Source : BSEThe Company has enclosing herewith copy of newspapers advetiement of financial resulst for the quarter and yaer ended 31.03.2026.
Result For FY Ended 31.03.2026
21-May-2026 | Source : BSEAudited Results for fiancial yaer ended 31.03.2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Krebs Biochemicals & Industries Ltd has announced 21:100 rights issue, ex-date: 31 Jan 19